| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
HABP2 |
HABP2, HGFAL, PHBP: Hyaluronan-binding protein 2 precursor |
0.265 |
Evidence |
|
| MAS1 |
MAS1, MAS: MAS proto-oncogene |
GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
0.265 |
Evidence |
|
| MAS1 |
MAS1, MAS: MAS proto-oncogene |
GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
0.265 |
Evidence |
|
| MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
TCF4 |
TCF4, ITF2, SEF2: Transcription factor 4 |
0.265 |
Evidence |
|
| TF |
TF, PRO1400: Serotransferrin precursor |
IGFBP2 |
IGFBP2, BP2, IBP2: Insulin-like growth factor-binding protein 2 precursor |
0.265 |
Evidence |
O
|
| HLA-DQB1 |
HLA-DQB, HLA-DRB1: HLA class II histocompatibility antigen, DQ(1) beta chain pre |
MICA |
MICA: MHC class I chain-related protein A |
0.265 |
Evidence |
|
| IL1B |
IL1B, IL1F2: Interleukin-1 beta precursor |
MYD88 |
|
0.265 |
Evidence |
|
| CSTA |
CSTA, STF1, STFA: Cystatin-A |
CAPN2 |
CAPN2, CANPL2: Calpain-2 catalytic subunit precursor |
0.265 |
Evidence |
|
| CSTA |
CSTA, STF1, STFA: Cystatin-A |
CAPN1 |
CAPN1, CANPL1: Calpain-1 catalytic subunit |
0.265 |
Evidence |
|
| AGT |
AGT, SERPINA8: Angiotensinogen precursor |
MASP1 |
MASP1, CRARF, CRARF1, PRSS5: Complement-activating component of Ra-reactive fact |
0.265 |
Evidence |
|
| SERPINA1 |
SERPINA1, AAT, PRO0684, PI, PRO2209: Alpha-1-antitrypsin precursor |
PRSS8 |
PRSS8: Prostasin precursor |
0.265 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
SHB |
SHB: SH2 domain-containing adapter protein B |
0.265 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
GRB7 |
GRB7: Growth factor receptor-bound protein 7 |
0.265 |
Evidence |
|
| CYB5R3 |
CYB5R3, DIA1: NADH-cytochrome b5 reductase 3 |
SRPX2 |
SRPX2, SRPUL: Sushi repeat-containing protein SRPX2 precursor |
0.265 |
Evidence |
|
| EDG6 |
EDG6: Sphingosine 1-phosphate receptor Edg-6 |
GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
0.265 |
Evidence |
|
| EDG6 |
EDG6: Sphingosine 1-phosphate receptor Edg-6 |
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
0.265 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
EDG7 |
EDG7, LPA3: Lysophosphatidic acid receptor Edg-7 |
0.265 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
NPFFR1 |
NPFFR1, GPR147, NPFF1: Neuropeptide FF receptor 1 |
0.265 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
P2RY11 |
P2RY11: P2Y purinoceptor 11 |
0.265 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
P2RY6 |
P2RY6, PP2891: P2Y purinoceptor 6 |
0.265 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
HTR5A |
HTR5A: 5-hydroxytryptamine receptor 5A |
0.265 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
GPR4 |
GPR4, GPR19: Probable G-protein coupled receptor 4 |
0.265 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
ADORA1 |
ADORA1: Adenosine receptor A1 |
0.265 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
HTR1E |
HTR1E: 5-hydroxytryptamine receptor 1E |
0.265 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
EDNRA |
EDNRA, ETA, ETRA: Endothelin-1 receptor precursor |
0.265 |
Evidence |
|